20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler

RxCUI
759471
RxNorm name
20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Display name
20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Full name
20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RELENZAZANAMIVIRA-S Medication Solutionsb4e68930-4e6d-4d27-b1f0-abf60d12e28d2026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 759471
RELENZAZANAMIVIRGlaxoSmithKline LLCd7c3bcc3-0c0d-4068-fd80-88cf54a376ef2023-10-24Warnings, Adverse reactionsExact identifier
rxcui: 759471

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d7c3bcc3-0c0d-4068-fd80-88cf54a376efzanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters [PSN] · 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [SCD] · zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT [SY]333These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir inhalation powder), for oral inhalation use Initial U.S. Approval: 199920231024
12ff22f6-20b5-4fa8-9028-58f87e169ff5zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters [PSN] · 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [SCD] · zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT [SY]31These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 199920100302
315556f2-4da0-47fc-86af-8fb61f6dd3bfzanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters [PSN] · 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [SCD] · zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT [SY]31These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 199920100302